28年之后,再次参加 Kenny G 的音乐会,才意识到他是刚过 70岁的人了。但远看,他身材精瘦,体姿端正,行动流畅,可以感觉到那种令人羡慕的对于身体各个部位的精准控制又不露痕迹,豪不费力的状态。如果从背后看,和一个 20多岁的年轻人并没有区别。
原本以为他大概是长期练习瑜伽才有这样的好状态。问了 ai 说主要还是长期台上表演的训练,打高尔夫球,还有对饮食的高度节制。另外长期吹萨克斯风可以培养对于横隔膜,呼吸和核心肌群的强大精准的控制能力,远超普通人的想象。
I keep hearing: “Easy for you to preach, Bryan. You’re already rich. Sacrificing health is the price of success.”
That's incorrect. Had I protected my body and brain, I’d be wealthier and more successful today. I would’ve also skipped a decade of tortuous depression.
I'm trying to help you avoid the same mistake. Culture is lying to you. You do not need to martyr yourself to be successful. You will be more successful if you prioritize your health.
Health is your compound-interest engine behind every other asset:
+ better decisions: sleep-restricted CEOs make 29% more risky errors in lab simulations.
▸ greater output: cardiorespiratory-fit workers log 2 extra productive hours per week.
▸ emotional stability: consistent exercise cuts depressive symptoms by ~25 % across 97 RCTs.
You only get one body and one brain. Run it down and you have nothing to work with. Burn it out and you're out of the game.
Health is your greatest asset. It's what allows you to work, reason, problem solve and persist. It enables a stable mood, clearheadedness, and good judgment.
Poor health leads to emotional turbulence, bad decision making, less energy, addictions, and sadness.
Health is forgotten until it's the only thing that matters.
You do not need to do what I do. I am trying to make a point of being the first Don't Die human prototype. I'm learning everything I can about ideal health and passing the learnings onto you.
You can do a fraction of what I do and get the majority of the benefits.
Here they are:
1. Make sleep your #1 life priority. Build your life around it.
2. Lower your resting heart rate before bed. You'll learn that which increases your RHR before bed is bad for you and that which lowers your RHR before bed is good for you. I've written a lot about the specifics you can do. Look it up.
3. Exercise every single day. Even if a 20-30 minute walk. Make it a habit. Never skip a day.
4. Build life systems and habits. Don't let your mind decide. You'll nearly always make the wrong decision in the moment.
5. Eat good things and avoid addictive things.
6. Prioritize relationships.
You can be ambitions AF and also be healthy. Culture is wrong in telling you that success is only achievable by martyring oneself. That's foolish.
Now do the right thing and go exercise and get to bed on time tonight. As you start feeling better, your ambitions will grow with your health status.
Trial it and you'll see what I'm talking about.
This is cool. The first real-world demonstration of a quantum-enhanced AI workflow producing experimentally validated drug leads for a notoriously "undruggable" cancer protein.
Offering a template for integrating quantum computing as a molecule generator in a hybrid model with classical AI models for groundbreaking drug discovery.
What they did: a research team from @InSilicoMedsand and @UofT leveraged a potent hybrid quantum-classical AI system to design novel small molecules capable of inhibiting mutant KRAS, a notoriously "undruggable" cancer protein.
KRAS is one of the most frequently mutated oncogenes across human cancers, particularly prevalent in lung, colorectal, and pancreatic tumors. These mutations hyperactivate the KRAS protein, leading to uncontrolled cell growth. For decades, KRAS was deemed "undruggable" due to its smooth surface and lack of deep binding pockets, making it incredibly challenging for small molecules to bind effectively and inhibit its function.
Given that KRAS mutations are responsible for approximately 25% of human cancers, often associated with poor prognoses and limited efficacy of existing drugs, it presents an ideal target for AI-driven drug discovery.
Congratulations to @biogerontology for this breakthrough.
Here are more details for those of you curious about AI drug discovery
1/ Quantum-Classical AI setup and workflow. Data and training.
A custom training set of 1.1 million molecules, including known KRAS binders, was compiled and used to train both the classical and quantum systems using Virtual Flow docking screening.
+ Generation of molecules: Hybrid Generative model
Quantum AI: Generator, Classical AI: discriminator.
A Quantum Circuit Born Machine (QCBM) ran on a quantum chip to generate new molecular structures.
A classical AI system (Insilico’s Chemistry42) evaluated those molecules, filtering for likely KRAS interaction
+ Filtering and identifying best drug candidates:
Using Chemistry42 a million QCBM-generated molecules were sampled, filtered according to their drug-likeness including absorption metabolism and toxicity, and then ranked based on their docking scores.
+ Chemical synthesis and real world validation
15 candidates were chosen, chemically synthesized, and tested in the lab .
2/ The main outcome
Two of the 15 molecules successfully inhibited multiple KRAS variants in live cells. Real experimental hits based on quantum AI generation (QCBM) coupled with classical AI (Chemistry42) screening and validation.
3/ Advantage of using Quantum Computing for drug discovery
Quantum systems are theoretically better at sampling from complex, high-dimensional distributions, which could help find unusual and novel molecules that classical systems might miss. But today, this is still experimental. No clear advantage has been proven yet.
4/ This study used a “real but limited” quantum computer
The study used real, hardware-based quantum processor (IBM Quantum’s superconducting qubits), not just a quantum simulator.
However, the scale and depth of the quantum computation were limited, and the scope of application was limited to the molecule generation step, while all the evaluation and optimization steps were performed by Chemistry42, a classical generative AI model.
5/ Significance
+ First experimental validation of quantum-AI drug generation
This is the first study to use a quantum generative model (QCBM) integrated with classical AI to design small molecules that were synthesized and shown to inhibit a real, disease-relevant target (KRAS) in vitro.
+ Demonstrates hybrid quantum–classical synergy
The study showcases a practical workflow, where quantum computing contributes to early-stage ideation, while classical AI tools like Chemistry42 handle evaluation and optimization.
+ Progress against the “undruggable” KRAS target
KRAS has long been considered one of the most challenging oncogenic proteins to target. Generating novel KRAS inhibitors using this approach highlights the potential of AI–quantum tools to tackle previously intractable targets.
+ Opens the door to expanding the chemical space
Quantum models can sample from non-intuitive, high-dimensional chemical spaces, potentially leading to new classes of molecules that classical methods might overlook.
+ Lays groundwork for scalable quantum drug discovery
While quantum advantage has not yet been demonstrated, this study is a foundational step showing that quantum hardware can be functionally integrated into real-world discovery pipelines.
6/ Limitations
+ Limited scale and maturity of quantum hardware
The quantum component (QCBM) was run on noisy, small-scale quantum hardware, limiting circuit depth and complexity. The study does not demonstrate quantum advantage over classical generative methods.
+ Narrow experimental validation
Only 15 molecules were synthesized, and just 2 showed modest in vitro activity against KRAS. There was no in vivo testing, pharmacokinetics, or toxicity data — so therapeutic potential remains speculative.
+ Single-target, proof-of-concept scope
The approach was tested on only one protein family (KRAS). It’s unclear how well this quantum–classical pipeline generalizes to other targets.
love my monday morning routine:
+ light in eyes (10000 lux)
+ hair serums/red light
+ blueprint pre-workout stack
+ 30 min strength/balance/flexibility
+ 30 min cardio
+ 20 min 200F sauna
+ 6 min whole body red/nir
+ shockwave on 4 joints (4500)
+ HBOT 90 min
+ excited